(Q42631112)

4 November 2017

title

Mutational analysis of CDKN2A gene in a group of 390 larynx cancer patients (English)

1 reference

4 November 2017

0 references

1 reference

1 reference

Andrzej Kram

3

0 references

Katarzyna Kiwerska

object named as

Katarzyna Kiwerska

1

0 references

Wenancjusz Domagała

object named as

Wenancjusz Domagała

6

0 references

Małgorzata Rydzanicz

2

object named as

Małgorzata Rydzanicz

1 reference

4 November 2017

7

Krzysztof Szyfter

1 reference

4 November 2017

Martyna Pastok

4

1 reference

4 November 2017

Agata Antkowiak

5

1 reference

4 November 2017

publication date

19 August 2009

1 reference

Molecular Biology Reports

4 November 2017

published in

1 reference

4 November 2017

volume

37

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

325-332

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-009-9731-z

4 November 2017

exact match

0 references

cites work

Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-009-9731-Z

The prognostic relevance of p16 inactivation in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-009-9731-Z

Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-009-9731-Z

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-009-9731-Z

Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.

21 January 2018

1 reference

12 December 2020

p16(MTS-1/CDKN2/INK4a) in cancer progression

1 reference

12 December 2020

Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival

1 reference

12 December 2020

A minimum folding unit in the ankyrin repeat protein p16(INK4)

1 reference

12 December 2020

p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx

1 reference

12 December 2020

Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4

1 reference

12 December 2020

DNA methylation markers and early recurrence in stage I lung cancer

1 reference

12 December 2020

Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.

1 reference

12 December 2020

Gene promoter hypermethylation in tumors and serum of head and neck cancer patients

1 reference

12 December 2020

Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers

1 reference

12 December 2020

Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers

1 reference

12 December 2020

p16 Mutation Frequency and Clinical Correlation in Head and Neck Cancer

1 reference

12 December 2020

Role of the INK4a locus in tumor suppression and cell mortality.

1 reference

12 December 2020

Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients

1 reference

12 December 2020

Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines.

1 reference

12 December 2020

CDKN2A common variants and their association with melanoma risk: a population-based study.

1 reference

12 December 2020

Frequent loss of chromosome 9p21-22 early in head and neck cancer progression

1 reference

12 December 2020

Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas

1 reference

12 December 2020

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

1 reference

12 December 2020

Differential alterations of the genes in the CDKN2A-CCND1-CDK4-RB1 pathway are associated with the development of head and neck squamous cell carcinoma in Indian patients

1 reference

12 December 2020

CDKN2A/p16 is inactivated in most melanoma cell lines

1 reference

12 December 2020

9p21 deletion correlates with recurrence in head and neck cancer

1 reference

12 December 2020

Rates of p16 (MTS1) mutations in primary tumors with 9p loss

1 reference

12 December 2020

Inactivation patterns of the p16 (INK4a) gene in oral squamous cell carcinoma cell lines

1 reference

12 December 2020

Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa

1 reference

12 December 2020

Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation

1 reference

12 December 2020

Functional evaluation of tumour-specific variants of p16INK4a/CDKN2A: correlation with protein structure information.

1 reference

12 December 2020

Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a

1 reference

12 December 2020

Patterns of gene promoter methylation in squamous cell cancer of the head and neck

1 reference

12 December 2020

Germline p16 mutations in familial melanoma

1 reference

12 December 2020

Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China

1 reference

12 December 2020

CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.

1 reference

12 December 2020

Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Germline Mutations of the CDKN2 Gene in UK Melanoma Families

1 reference

12 December 2020

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

1 reference

12 December 2020

Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors

1 reference

12 December 2020

Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV

1 reference

12 December 2020

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

1 reference

12 December 2020

Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer

1 reference

12 December 2020

Does loss of heterozygosity in critical genome regions predict a local relapse in patients after laryngectomy?

1 reference

12 December 2020

High prevalence of p16 genetic alterations in head and neck tumours

1 reference

12 December 2020

INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.

1 reference

12 December 2020

High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma

1 reference

12 December 2020

Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines.

1 reference

12 December 2020

Mutations associated with familial melanoma impair p16INK4 function.

1 reference

12 December 2020

DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area.

1 reference

12 December 2020

p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer.

1 reference

12 December 2020

Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck.

1 reference

12 December 2020

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

12 December 2020

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

1 reference

12 December 2020

10.1007/S11033-009-9731-Z

Identifiers

DOI

1 reference

4 November 2017

1 reference